The Cytel Blog: Perspectives on Enquiry & Evidence

Traditionally, the teams responsible for clinical development and regulatory submissions do not consult the market..

Since its first publication ten years ago, Cyrus Mehta and Stuart Pocock’s Promising Zone Design for sample size..

The value of Real World Evidence (RWE) is well known to many stakeholders, but its full potential for market access and..

There are many reasons why traditional approaches to designing a clinical study are generally suboptimal and do not..

Ten years ago Cytel co-founder Professor Cyrus Mehta and Professor Stuart Pocock of the London School of Hygiene and..

The prominent European conference for Health Economics and Outcomes Research (HEOR), ISPOR Europe 2021, is around the..

A good clinical study design performs well not only under the ideal target scenario. Statisticians should be able to..

A platform trial, a type of Master Protocol, is an experimental infrastructure to evaluate multiple treatments and/or..

A staged investment strategy aligns R&D decisions and financial planning with the interim looks of a clinical trial. If..